Hypertension Prevalence, Awareness, Treatment, and Control in Egypt

We evaluated the prevalence, awareness, treatment, and control of hypertension (defined as a systolic blood pressure [BP]) ≥140 mm Hg, diastolic BP ≥90 mm Hg, or a self-reported use of an antihypertensive agent) among US adults, stratified by race/ethnicity. This analysis included 16 531 nonpregnant US adults (≥18 years) in the three National Health and Nutrition Examination Survey cycles between 2013 and 2018. Race/ethnicity was defined by self-report as White, Black, Hispanic, Asian, or other Americans. Among 76 910 050 (74 449 985–79 370 115) US adults with hypertension, 48.6% (47.3%–49.8%, unadjusted) have controlled BP. When compared with BP control rates for White adults (49.0% [46.8%–51.2%], age-adjusted), BP control rates are lower in Black (39.2%, adjusted odds ratio [aOR], 0.71 [95% CI, 0.59–0.85], P <0.001), Hispanic (40.0%, aOR, 0.71 [95% CI, 0.58–0.88], P =0.003), and Asian (37.8%, aOR, 0.68 [95% CI, 0.55–0.84], P =0.001) Americans. Black adults have higher hypertension prevalence (45.3% versus 31.4%, aOR, 2.24 [95% CI, 1.97–2.56], P <0.001) but similar awareness and treatment rates as White adults. Hispanic adults have similar hypertension prevalence, but lower awareness (71.1% versus 79.1%, aOR, 0.72 [95% CI, 0.58–0.89], P =0.005) and treatment rates (60.5% versus 67.3%, aOR, 0.78 [95% CI, 0.66–0.94], P =0.010) than White adults. Asian adults have similar hypertension prevalence, lower awareness (72.5% versus 79.1%, aOR, 0.75 [95% CI, 0.58–0.97], P =0.038) but similar treatment rates. Black, Hispanic, and Asian Americans have different vulnerabilities in the hypertension control cascade of prevalence, awareness, treatment, and control. These differences can inform targeted public health efforts to promote health equity and reduce the burden of hypertension in the United States.

Download Full-text

Long-term Trends in Hypertension Prevalence, Awareness, Treatment, and Control Rate in the Middle East and North Africa: a Systematic Review and Meta-analysis of 178 Population-Based Studies

Current Hypertension Reports ◽

10.1007/s11906-021-01159-0 ◽

2021 ◽

Vol 23 (9) ◽

Author(s):

Nami Mohammadian Khonsari ◽

Ehsan Shahrestanaki ◽

Hanieh-Sadat Ejtahed ◽

Shirin Djalalinia ◽

Ali Sheidaei ◽

...

Keyword(s):

Systematic Review ◽

Middle East ◽

North Africa ◽

Meta Analysis ◽

Population Based ◽

Hypertension Prevalence ◽

Long Term Trends ◽

And Control

Download Full-text

Abstract 15595: Missed Targets: United States Trends in Hypertension Prevalence, Control, and Treatment 2005-2018

Circulation ◽

10.1161/circ.142.suppl_3.15595 ◽

2020 ◽

Vol 142 (Suppl_3) ◽

Author(s):

Rahul Aggarwal ◽

Nicholas Chiu ◽

Rishi Wadhera ◽

Changyu Shen ◽

Robert W Yeh ◽

...

Keyword(s):

Blood Pressure ◽

Temporal Trends ◽

Cost Effective ◽

Pressure Control ◽

Healthy People ◽

Sensitivity Analyses ◽

Base Case ◽

Improve Blood Pressure Control ◽

Hypertension Prevalence ◽

And Control

Introduction: Hypertension is a major risk factor for cardiovascular disease. The US government, through the Healthy People Initiative 2020, set targets to improve hypertension prevalence and treatment rates in US adults by a relative 10% from 2005 to 2020, and increase control rates by a relative 40%. We examined US progress towards this goal from 2005-2018. Methods: We analyzed data from 38,876 non-pregnant US adults from the NHANES 2005-2018 surveys to determine nationally representative estimates of hypertension prevalence, treatment rates, and control. Temporal trends in hypertension prevalence, treatment, and control were assessed using weighted linear regression after age adjustment to the 2000 US census (per the Healthy People Initiative approach). In the base case, we defined hypertension as blood pressure >140/90 or on an antihypertensive; we used the ACC/AHA definition of blood pressure >130/80 in sensitivity analyses. Results: In 2017-2018, 34.3% (±1.7) of US adults had hypertension, of these 69.7% (±1.5) were on treatment, and 43.7% (±1.6) were controlled. After age-adjustment, no statistically significant changes in hypertension prevalence, treatment rates, or control were observed from 2005-2018 (p for trend 0.91, ,0.98, 0.66, Figure 1). In sensitivity analyses, applying the ACC/AHA definition increased the estimated prevalence of hypertension during the period, but trends in prevalence remained unchanged. Conclusions: There has been no material progress in reducing the prevalence of hypertension or improving rates of treatment and control from 2005 to 2018. As planning is underway for Healthy People Initiative 2030, setting of hypertension targets must be accompanied with investments in cost-effective, scalable programs to improve blood pressure control nationwide, with a focus on high-risk populations.

Download Full-text

Hypertension Prevalence, Awareness, Treatment, and Control and Sodium Intake in Shandong Province, China: Baseline Results From Shandong–Ministry of Health Action on Salt Reduction and Hypertension (SMASH), 2011

Preventing Chronic Disease ◽

10.5888/pcd11.130423 ◽

2014 ◽

Vol 11 ◽

Cited By ~ 24

Author(s):

Zhenqiang Bi ◽

Xiaofeng Liang ◽

Aiqiang Xu ◽

Linghong Wang ◽

Xiaoming Shi ◽

...

Keyword(s):

Sodium Intake ◽

Shandong Province ◽

Ministry Of Health ◽

Salt Reduction ◽

Hypertension Prevalence ◽

Health Action ◽

And Control

Download Full-text

Hypertension prevalence, associated factors, treatment, and control in rural Cameroon: a cross-sectional study

10.21203/rs.3.rs-31780/v1 ◽

2020 ◽

Author(s):

Larissa Pone Simo ◽

Valirie Ndip Agbor ◽

Jean Jacques Noubiap ◽

Orlin Pagnol Nana ◽

Pride Swiri-Muya Nkosu ◽

...

Keyword(s):

Rural Communities ◽

Rural Community ◽

Associated Factors ◽

Cross Sectional Study ◽

Sectional Study ◽

Cross Sectional ◽

Hypertension Prevalence ◽

History Of ◽

Family History Of Hypertension ◽

And Control

Abstract Introduction: Sub-Saharan Africa is experiencing a surge in the burden of hypertension, and rural communities seem to be increasingly affected by the epidemic. Objectives: We aimed to determine the prevalence of hypertension, its associated factors, as well as its awareness, treatment, and control rates in rural communities of the Baham Health District (BHD), Cameroon.Design: A community-based cross-sectional study.Setting: Participants from five health areas in the BHD were recruited from August to October 2018.Participants: Consenting participants aged 18 years or older were included. Results: We included 526 participants in this study. The median age of the participants was 53.0 (IQR = 35 – 65) years and 67.1% were female. The prevalence of hypertension was 40.9% (95% confidence interval [CI] = 36.7 – 45.1) were hypertensive with no gender disparity. The overall age-standardised prevalence of hypertension was 23.9% (95% CI = 20.3 – 27.5). Five-year increase in age (adjusted odd’s ratio [AOR] = 1.34; 95% CI = 1.23 – 1.44), family history of hypertension (AOR = 2.22; 95% CI = 1.37 – 3.60), and obesity were associated with higher odds of hypertension (AOR = 2.57; 95% CI = 1.40 – 4.69).The rates of awareness, treatment, and control of hypertension were 37.2% (95% CI = 31.0 – 43.9), 20.9% (95% CI = 16.0 – 26.9), and 22.2% (95% CI = 15.2 – 46.5), respectively.Conclusion: The high hypertension prevalence in this rural community is associated with contrastingly low awareness, treatment, and control rates. Age, family history of hypertension, and obesity are the major drivers of hypertension in this community. Veracious policies are needed to improve awareness, prevention, diagnosis, treatment, and control of hypertension in this rural community.

Download Full-text

Abstract 604: Differences In The Prevalence And Control Of Hypertension Between Mercury Sphygmomanometer And Omron (hem_907xl): Nhanes 2009-2010

Hypertension ◽

10.1161/hyp.60.suppl_1.a604 ◽

2012 ◽

Vol 60 (suppl_1) ◽

Author(s):

Sarah Yoon ◽

Tatiana Nwankwo ◽

Margaret Carroll ◽

Yechiam Ostchega

Keyword(s):

Blood Pressure ◽

Data Interpretation ◽

Hypertension Control ◽

Blood Pressure Monitor ◽

Pressure Monitor ◽

Hypertension Prevalence ◽

Health And Nutrition ◽

Subgroup Analyses ◽

And Control ◽

Mercury Sphygmomanometer

Objectives - Precise, reliable blood pressure (BP) measurement, whether in clinical practice or in epidemiological research, is essential for diagnosis and data interpretation. The study objectives were to compare differences in the prevalence and control of hypertension among adults aged 18 years and older using two standard devices: the mercury sphygmomanometer and the Omron Digital Blood Pressure Monitor (HEM_907XL). Methods - 5,185 individuals aged 18 years and older participated in the National Health and Nutrition Examination Survey 2009-2010 BP methodology study. Hypertension was defined as a mean systolic blood pressure (SBP) ≥ 140 mmHg or diastolic blood pressure (DBP) ≥ 90 mmHg, or currently taking BP medication. Mean BP was the average of up to three readings for each device. Controlled Hypertension among hypertensives was defined as SBP <140 mmHg and DBP < 90 mmHg. Results - Overall the age-adjusted prevalence of hypertension among adults was higher by mercury measurement (27.7%) than by Omron (26.4%, p <0.05). There were significant differences in hypertension prevalence between the two devices among men (mercury: 28.9% vs. Omron: 26.5%, p < 0.05) and Hispanics (mercury: 25.1% vs. Omron: 22.8%, p < 0.05). The overall hypertension control rate among hypertensives was significantly higher using Omron (64.6%) vs. mercury measurement (57.5%, p <0.05). In subgroup analyses, rates of hypertension control among hypertensives were systematically higher using Omron: for those 40-59 years (mercury: 60.0%; Omron: 67.9%); for those 60 years and older (mercury: 59.7%; Omron: 65.4%); for men (mercury: 54.9%; Omron: 63.9%); women (mercury: 61.5%; Omron: 66.1%,); non-Hispanic whites (mercury: 60.9%; Omron: 68.4%); non-Hispanic blacks(mercury: 48.8%; Omron: 54.3%); and Hispanics (mercury: 34.6%; Omron: 44.8%), ( p <0.05 for all groups). Conclusion - Hypertension prevalence measured by mercury was significantly higher than that measured by the Omron device. Lower Omron readings resulted in apparently higher estimates for the rate of controlled hypertension.

Download Full-text